11/12/2024 10:38 AM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form PRE 14A | |
10/18/2024 3:42 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 4:18 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 2:30 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/16/2024 5:54 AM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 424B5 | |
10/02/2024 2:45 PM | Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer) Shankman Michael Elliot (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/02/2024 11:21 AM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
09/23/2024 12:28 PM | Boos Wayne W (Filed by) Lexaria Bioscience Corp. (Subject) Lexaria Bioscience Corp. (Subject) Lexaria Bioscience (Subject)
| Form SC 13D/A | |
09/05/2024 12:09 PM | CHRISTOPHER RICHARD (Reporting) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/05/2024 9:11 AM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/21/2024 6:55 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 9:55 AM | Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer) TURKEL CATHERINE C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 11:25 AM | Carle Vanessa (Reporting) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 10:39 AM | Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer) REESE ALBERT L JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 10:25 AM | Baxter Nicholas W (Reporting) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 10:32 AM | Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer) TURKEL CATHERINE C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2024 10:12 AM | Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer) McKechnie William Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2024 12:26 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/11/2024 11:15 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form EFFECT | |
06/03/2024 12:05 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
05/15/2024 4:37 PM | Carle Vanessa (Reporting) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 4:16 PM | Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer) TURKEL CATHERINE C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 4:24 PM | Carle Vanessa (Reporting) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 4:03 PM | Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer) McKechnie William Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 4:11 PM | Baxter Nicholas W (Reporting) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 3:34 PM | DOCHERTY JOHN MARTIN (Reporting) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 3:44 PM | BUNKA CHRISTOPHER (Reporting) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 1:18 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form D Notice of Exempt Offering of Securities | |
04/30/2024 2:13 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2024 3:57 PM | Boos Wayne W (Filed by) Lexaria Bioscience Corp. (Subject) Lexaria Bioscience Corp. (Subject) Lexaria Bioscience (Subject)
| Form SC 13D/A | |
04/24/2024 10:38 AM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/09/2024 3:12 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/21/2024 3:37 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 11:15 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form EFFECT | |
03/20/2024 4:00 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 424B3 | |
03/15/2024 3:22 PM | Cabatuan Nelson (Reporting) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience Corp. (Issuer) Lexaria Bioscience (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/15/2024 3:09 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2024 4:09 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
03/06/2024 5:00 AM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form DEF 14A | |
03/01/2024 1:28 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 3:30 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Shocking footage from Bill Gates’ $100,000,000,000 AI Bet (Ad) If you missed out on Nvidia, watch this video I just made. Click here for full details. |
02/16/2024 2:47 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form D Notice of Exempt Offering of Securities | |
02/16/2024 5:01 AM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 424B5 | |
02/14/2024 1:20 PM | Boos Wayne W (Filed by) Lexaria Bioscience Corp. (Subject) Lexaria Bioscience Corp. (Subject) Lexaria Bioscience (Subject)
| Form SC 13D/A | |
02/14/2024 11:00 AM | Invenomic Capital Management LP (Filed by) Lexaria Bioscience Corp. (Subject) Lexaria Bioscience Corp. (Subject) Lexaria Bioscience (Subject)
| Form SC 13G/A | |
01/28/2024 11:15 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form EFFECT | |
01/24/2024 12:33 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form POS AM | |
01/18/2024 1:38 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/12/2024 4:11 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
12/10/2023 11:15 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form EFFECT | |
12/08/2023 3:31 PM | Lexaria Bioscience Corp. (Filer) Lexaria Bioscience Corp. (Filer) Lexaria Bioscience (Filer)
| Form 424B3 | |